206 related articles for article (PubMed ID: 35011303)
21. Novel Inhibitors of DNA Repair Enzyme TDP1 Combining Monoterpenoid and Adamantane Fragments.
Mozhaitsev ES; Zakharenko AL; Suslov EV; Korchagina DV; Zakharova OD; Vasil'eva IA; Chepanova AA; Black E; Patel J; Chand R; Reynisson J; Leung IKH; Volcho KP; Salakhutdinov NF; Lavrik OI
Anticancer Agents Med Chem; 2019; 19(4):463-472. PubMed ID: 30523770
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.
Lv PC; Agama K; Marchand C; Pommier Y; Cushman M
J Med Chem; 2014 May; 57(10):4324-36. PubMed ID: 24800942
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening.
Mamontova EM; Zakharenko AL; Zakharova OD; Dyrkheeva NS; Volcho KP; Reynisson J; Arabshahi HJ; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2020 Jan; 28(1):115234. PubMed ID: 31831297
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Biological Activities of 11- and 12-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB and Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
Yang H; Qin C; Wu M; Wang FT; Wang W; Agama K; Pommier Y; Hu DX; An LK
ChemMedChem; 2023 May; 18(10):e202200593. PubMed ID: 36932053
[TBL] [Abstract][Full Text] [Related]
25. Novel TDP1 Inhibitors: Disubstituted Thiazolidine-2,4-Diones Containing Monoterpene Moieties.
Ivankin DI; Kornienko TE; Mikhailova MA; Dyrkheeva NS; Zakharenko AL; Achara C; Reynisson J; Golyshev VM; Luzina OA; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835244
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).
Conda-Sheridan M; Reddy PV; Morrell A; Cobb BT; Marchand C; Agama K; Chergui A; Renaud A; Stephen AG; Bindu LK; Pommier Y; Cushman M
J Med Chem; 2013 Jan; 56(1):182-200. PubMed ID: 23259865
[TBL] [Abstract][Full Text] [Related]
27. Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy.
Khomenko TM; Zakharenko AL; Chepanova AA; Ilina ES; Zakharova OD; Kaledin VI; Nikolin VP; Popova NA; Korchagina DV; Reynisson J; Chand R; Ayine-Tora DM; Patel J; Leung IKH; Volcho KP; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878088
[TBL] [Abstract][Full Text] [Related]
28. New Hybrid Compounds Combining Fragments of Usnic Acid and Monoterpenoids for Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibition.
Dyrkheeva NS; Filimonov AS; Luzina OA; Zakharenko AL; Ilina ES; Malakhova AA; Medvedev SP; Reynisson J; Volcho KP; Zakian SM; Salakhutdinov NF; Lavrik OI
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356597
[TBL] [Abstract][Full Text] [Related]
29. Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors.
Kiselev E; Ravji A; Kankanala J; Xie J; Wang Z; Pommier Y
DNA Repair (Amst); 2020 Jan; 85():102747. PubMed ID: 31775111
[TBL] [Abstract][Full Text] [Related]
30. [Tyrosyl-DNA phosphodiesterases: potential targets for cancer treatment].
Hu Z; Wang HW; An LK
Yao Xue Xue Bao; 2016 Feb; 51(2):215-25. PubMed ID: 29856574
[TBL] [Abstract][Full Text] [Related]
31. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures.
Davies DR; Interthal H; Champoux JJ; Hol WG
J Mol Biol; 2002 Dec; 324(5):917-32. PubMed ID: 12470949
[TBL] [Abstract][Full Text] [Related]
32. Usnic Acid Derivatives Inhibit DNA Repair Enzymes Tyrosyl-DNA Phosphodiesterases 1 and 2 and Act as Potential Anticancer Agents.
Zakharenko AL; Dyrkheeva NS; Luzina OA; Filimonov AS; Mozhaitsev ES; Malakhova AA; Medvedev SP; Zakian SM; Salakhutdinov NF; Lavrik OI
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895279
[TBL] [Abstract][Full Text] [Related]
33. Monoterpene substituted thiazolidin-4-ones as novel TDP1 inhibitors: Synthesis, biological evaluation and docking.
Ivankin DI; Dyrkheeva NS; Zakharenko AL; Ilina ES; Zarkov TO; Reynisson J; Luzina OA; Volcho KP; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem Lett; 2022 Oct; 73():128909. PubMed ID: 35907608
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.
Nguyen TX; Abdelmalak M; Marchand C; Agama K; Pommier Y; Cushman M
J Med Chem; 2015 Apr; 58(7):3188-208. PubMed ID: 25811317
[TBL] [Abstract][Full Text] [Related]
35. Discovery of Novel Sultone Fused Berberine Derivatives as Promising Tdp1 Inhibitors.
Gladkova ED; Chepanova AA; Ilina ES; Zakharenko AL; Reynisson J; Luzina OA; Volcho KP; Lavrik OI; Salakhutdinov NF
Molecules; 2021 Mar; 26(7):. PubMed ID: 33808389
[TBL] [Abstract][Full Text] [Related]
36. Discovery of selective inhibitors of tyrosyl-DNA phosphodiesterase 2 by targeting the enzyme DNA-binding cleft.
Kossmann BR; Abdelmalak M; Lopez S; Tender G; Yan C; Pommier Y; Marchand C; Ivanov I
Bioorg Med Chem Lett; 2016 Jul; 26(14):3232-3236. PubMed ID: 27262595
[TBL] [Abstract][Full Text] [Related]
37. Design, Synthesis, and Biological Investigation of Novel Classes of 3-Carene-Derived Potent Inhibitors of TDP1.
Il'ina IV; Dyrkheeva NS; Zakharenko AL; Sidorenko AY; Li-Zhulanov NS; Korchagina DV; Chand R; Ayine-Tora DM; Chepanova AA; Zakharova OD; Ilina ES; Reynisson J; Malakhova AA; Medvedev SP; Zakian SM; Volcho KP; Salakhutdinov NF; Lavrik OI
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751997
[TBL] [Abstract][Full Text] [Related]
38. Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors.
Huang SN; Pommier Y; Marchand C
Expert Opin Ther Pat; 2011 Sep; 21(9):1285-92. PubMed ID: 21843105
[TBL] [Abstract][Full Text] [Related]
39. Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy.
Komarova AO; Drenichev MS; Dyrkheeva NS; Kulikova IV; Oslovsky VE; Zakharova OD; Zakharenko AL; Mikhailov SN; Lavrik OI
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1415-1429. PubMed ID: 30191738
[TBL] [Abstract][Full Text] [Related]
40. Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential.
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2016 Nov; 24(21):5017-5027. PubMed ID: 27687971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]